0001562180-16-003206.txt : 20161004 0001562180-16-003206.hdr.sgml : 20161004 20161004161212 ACCESSION NUMBER: 0001562180-16-003206 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20161001 FILED AS OF DATE: 20161004 DATE AS OF CHANGE: 20161004 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Akebia Therapeutics, Inc. CENTRAL INDEX KEY: 0001517022 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 208756903 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 245 FIRST STREET STREET 2: SUITE 1100 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-871-2098 MAIL ADDRESS: STREET 1: 245 FIRST STREET STREET 2: SUITE 1100 CITY: CAMBRIDGE STATE: MA ZIP: 02142 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hadas Nicole R. CENTRAL INDEX KEY: 0001602396 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36352 FILM NUMBER: 161918968 MAIL ADDRESS: STREET 1: 20 PILGRAM DRIVE CITY: WINCHESTER STATE: MA ZIP: 01890 4 1 primarydocument.xml PRIMARY DOCUMENT X0306 4 2016-10-01 false 0001517022 Akebia Therapeutics, Inc. AKBA 0001602396 Hadas Nicole R. C/O AKEBIA THERAPEUTICS, INC. 245 FIRST STREET CAMBRIDGE MA 02142 false true false false SVP, General Counsel, Sec. Common Stock 2016-10-01 4 S false 1556.00 8.9548 D 83915.00 D Shares sold by reporting person to pay taxes in connection with the vesting of restricted stock pursuant to a December 23, 2013 award. Twenty-five percent of the shares vested on December 2, 2014, and the remaining shares vest in equal quarterly installments through December 2, 2017. John P. Butler, Attorney-in-Fact for Nicole R. Hadas 2016-10-04